Gut microbiota composition and development of atopic manifestations in infancy: The KOALA birth cohort study

Gut

Volumn 56, Issue 5, 2007, Pages 661-667

  Penders, John ^a   Thijs, Carel ^b   Van Den Brandt, Piet A ^a   Kummeling, Ischa ^a   Snijders, Bianca ^a   Stelma, Foekje ^d   Adams, Hanne ^d   Van Ree, Ronald ^c   Stobberingh, Ellen E ^d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ALLERGIC REACTION; ARTICLE; ATOPIC DERMATITIS; ATOPY; BACTERIAL COLONIZATION; BIRTH CONTROL; BLOOD SAMPLING; CLOSTRIDIUM DIFFICILE; CONGENITAL SKIN DISEASE; CONTROLLED STUDY; DNA PURIFICATION; ECZEMA; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HUMAN; INFANT; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; SENSITIZATION; WHEEZING;

BACTERIA; CLOSTRIDIUM DIFFICILE; DERMATITIS, ATOPIC; DNA, BACTERIAL; ESCHERICHIA COLI; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; INFANT; MALE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY SOUNDS;

EID: 34247466932     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.100164     Document Type: Article

References (57)

1. Beasley R, Keil U, von Mutius E, et al. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225-32.
2. Ngoc PL, Gold DR, Tzianabos AO, et al. Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol 2005;5:161-6.
3. Nowak D, Suppli Ulrik C, von Mutius E. Asthma and atopy: has peak prevalence been reached? Eur Respir J 2004;23:359-60.
4. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299:1259-60.
5. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000;55(Suppl 1):S2-10.
6. Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol 2004;12:562-8.
7. Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut 2005;54:317-20.
8. Bjorksten B, Naaber P, Sepp E, et al. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999;29:342-6.
9. Bjorksten B, Sepp E, Julge K, et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001;108:516-20.
10. Watanabe S, Narisawa Y, Arase S, et al. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 2003;111:587-91.
11. Kalliomaki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001;107:129-34.
12. Bjorksten B. Effects of intestinal microflora and the environment on the development of asthma and allergy. Springer Semin Immunopathol 2004;25:257-70.
13. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-85.
14. Isolauri E, Arvola T, Sutas Y, et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30:1604-10.
15. Weston S, Halbert A, Richmond P, et al. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005;90:892-7.
16. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-9.
17. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003;361:1869-71.
18. Boyle RJ, Tang ML. The role of probiotics in the management of allergic disease. Clin Exp Allergy 2006;36:568-76.
19. Brouwer ML, Wolt-Plompen SA, Dubois AE, et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006;36:899-906.
20. Kummeling I, Thijs C, Penders J, et al. Etiology of atopy in infancy: the KOALA Birth Cohort Study. Pediatr Allergy Immunol 2005;16:679-84.
21. Bastiaanssen JM, de Bie RA, Bastiaenen CH, et al. Etiology and prognosis of pregnancy-related pelvic girdle pain; design of a longitudinal study. BMC Public Health 2005;5:1.
22. Williams HC, Burney PG, Hay RJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994;131:383-96.
23. Williams HC, Burney PG, Pembroke AC, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994;131:406-16.
24. Williams HC, Burney PG, Strachan D, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 1994;131:397-405.
25. Penders J, Thijs C, Vink C, et al. Factors influencing the intestinal microbiota in early infancy. Pediatrics 2006,118:511- 21.
26. Penders J, Vink C, Driessen C, et al. Quantification of Bifidobacterium spp. Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett 2005;243:141-7.
27. Huijsdens XW, Linskens RK, Mak M, et al. Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol 2002;40:4423-7.
28. Liu C, Song Y, McTeague M, et al. Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers. FEMS Microbiol Lett 2003;222:9-16.
29. Walter J, Hertel C, Tannock GW, et al. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 2001;67:2578-85.
30. Rinttila T, Kassinen A, Malinen E, et al. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 2004;97:1166-77.
31. Heilig HGHJ, Zoetendal EG, Vaughan EE, et al. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol 2002;68:114-23.
32. Nadkarni MA, Martin FE, Jacques NA, et al. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 2002;148:257-66.
33. Aalberse RC, Koshte V, Clemens JG. Immunoglobulin E antibodies that crossreact with vegetable foods, pollen, and Hymenoptera venom. J Allergy Clin Immunol 1981;68:356-64.
34. Stallman PJ, Aalberse RC. Estimation of basophil-bound IgE by quantitative immunofluorescence microscopy. Int Arch Allergy Appl Immunol 1977;54:9-18.
35. Schuurman J, Perdok GJ, Lourens TE, et al. Production of a mouse/human chimeric IgE monoclonal antibody to the house dust mile allergen Der p 2 and its use for the absolute quantification of allergen-specific IgE. J Allergy Clin Immunol 1997;99:545-50.
36. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995;8:483-91.
37. Furrie E. A molecular revolution in the study of intestinal microflora. Gut 2006;55:141-3.
38. Tannock GW. Analysis of the intestinal microflora: a renaissance. Antonie Van Leeuwenhoek 1999;76:265-78.
39. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004;4:478-85.
40. Mai V, Morris JG Jr. Colonic bacterial flora: changing understandings in the molecular age. J Nutr 2004;134:459-64.
41. Ott SJ, Musfeldt M, Timmis KN, et al. In vitro alterations of intestinal bacterial microbiota in fecal samples during storage. Diagn Microbiol Infect Dis 2004;50:237-45.
42. Edwards CA, Parrett AM. Intestinal flora during the first months of life: new perspectives. Br J Nutr 2002;88(Suppl 1):11-18.
43. Kusel MM, Holt PG, de Klerk N, et al. Support for 2 variants of eczema. J Allergy Clin Immunol 2005;116:1067-72.
44. Bottcher MF, Nordin EK, Sandin A, et al. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 2000;30:1590-6.
45. Woodcock A, Moradi M, Smillie FI, et al. Clostridium difficile, atopy and wheeze during the first year of life. Pediatr Allergy Immunol 2002;13:357-60.
46. Linneberg A, Ostergaard C, Tvede M, et al. IgG antibodies against microorganisms and atopic disease in Danish adults: the Copenhagen Allergy Study. J Allergy Clin Immunol 2003;111:847-53.
47. Sepp E, Julge K, Mikelsaar M, et al. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 2005;35:1141-6.
48. Kirjavainen PV, Apostolou E, Arvola T, et al. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 2001;32:1-7.
49. Stockebrandt E, Kramer I, Swiderski J, et al. Phylogenetic basis for a taxonomic dissection of the genus Clostridium. FEMS Immunol Med Microbiol 1999;24:253-8.
50. Fanaro S, Chierici R, Guerrini P, et al. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 2003;91:48-55.
51. Karisson H, Hessle C, Rudin A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immun 2002;70:6688-96.
52. Pothoulakis C. Effects of Clostridium difficile toxins on epithelial cell barrier. Ann N Y Acad Sci 2000;915:347-56.
53. Feltis BA, Wiesner SM, Kim AS, et al. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes. Shock 2000;14:629-34.
54. Majamaa H, Isolauri E. Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema. J Allergy Clin Immunol 1996;97:985-90.
55. Benard A, Desreumeaux P, Huglo D, et al. Increased intestinal permeability in bronchial asthma. J Allergy Clin Immunol 1996;97:1173-8.
56. Caffarelli C, Cavagni G, Menzies IS, et al. Elimination diet and intestinal permeability in atopic eczema: a preliminary study. Clin Exp Allergy 1993;23:28-31.
57. Pike MG, Heddle RJ, Boulton P, et al. Increased intestinal permeability in atopic eczema. J Invest Dermatol 1986;86:101-4.